← Back to Search

Group 2 for Sleep Disorder

N/A
Waitlist Available
Research Sponsored by Rothman Institute Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Summary

The purpose of this study is to determine whether melatonin when used as a supplement after surgery improves sleep following total joint arthroplasty

Eligible Conditions
  • Sleep Disorder
  • Total Joint Replacement

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient Sleep Quality

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Group 2Active Control1 Intervention
Melatonin (6mg)
Group II: Group 1Placebo Group1 Intervention
Placebo Tablet

Find a Location

Who is running the clinical trial?

Rothman Institute OrthopaedicsLead Sponsor
125 Previous Clinical Trials
22,304 Total Patients Enrolled
~21 spots leftby Sep 2025